The Austen BioInnovation Institute in Akron (ABIA) has created its first company: a firm that’s developing a noninvasive spinal fixation system for children with scoliosis.
APTO Orthopaedics’ device is designed to eliminate the need for repetitive, painful and costly surgeries for children with scoliosis, who can require up to two surgeries per year to adjust implants for their growing spines, according to a statement from the ABIA.
“This technology would allow surgeons to lengthen the spinal implants in an incision-less manner that would enable reduction in the expense, trauma and risk that accompany current procedures,” said Dr. Todd Ritzman, cofounder of the company and a physician at Akron Children’s Hospital.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
APTO’s key next steps involve continuing work to develop a prototype of the device, and after that, beginning to test the device on animals, an ABIA official said.
The U.S. spinal implants market is valued at $6.8 billion annually, according to the statement.
The ABIA was formed in 2008 as a result of the collaboration among several Akron institutions: Akron Children’s Hospital, Akron General Health System, Northeast Ohio Medical University, Summa Health System, The University of Akron and the John S. and James L. Knight Foundation.
Within a decade, the ABIA wants to create 2,400 new jobs and attract at least $50 million worth of investments annually in area healthcare companies, the Akron Beacon-Journal reported.
[Photo from flickr user nowhere Zen New Jersey]